Capital World Investors Kronos Bio, Inc. Transaction History

Capital World Investors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.12 - $7.52 $9.61 Million - $23.2 Million	-3,080,633 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$6.26 - $14.42 $443,089 - $1.02 Million	-70,781 Reduced 2.25%	3,080,633 $22.3 Million
Q2 2021 Aug 16, 2021	BUY	$20.08 - $29.02 $23.4 Million - $33.8 Million	1,164,874 Added 58.64%	3,151,414 $75.5 Million
Q1 2021 May 14, 2021	BUY	$27.0 - $32.48 $53.6 Million - $64.5 Million	1,986,540 New	1,986,540 $58.1 Million

19.8M

9.3K

100

Ticker KRON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,769,100
Market Cap $48.8M
Description
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

Stay updated on Capital World Investors with notifications on news.